id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0655-0039,FDA,FDA-2011-N-0655,AGDUFA IV Summary of Public Comments,Other,Summary (SUM),2022-12-16T05:00:00Z,2022,12,2022-12-16T05:00:00Z,,2022-12-16T20:17:03Z,,0,0,090000648553d4c0
FDA-2011-N-0655-0037,FDA,FDA-2011-N-0655,PUBLIC WORKSHOP – ANIMAL GENERIC DRUG USER FEE ACT (AGDUFA) REAUTHORIZATION: FY 2024 - 2028,Other,Transcript(s),2022-11-16T05:00:00Z,2022,11,2022-11-16T05:00:00Z,,2022-11-16T23:03:57Z,,0,0,09000064854bc355
FDA-2011-N-0655-0034,FDA,FDA-2011-N-0655,"Animal Generic Drug User Fee Act (AGDUFA) Reauthorization: FY 2024 –2028 Public Meeting October 26, 2022",Other,Presentation,2022-10-31T04:00:00Z,2022,10,2022-10-31T04:00:00Z,,2022-11-04T15:32:15Z,,0,0,090000648546d3ea
FDA-2011-N-0655-0033,FDA,FDA-2011-N-0655,Public Meeting on the Recommendations for Animal Generic Drug User Fee Act (AGDUFA) Reauthorization,Other,Agenda,2022-10-24T04:00:00Z,2022,10,2022-10-24T04:00:00Z,,2022-10-24T15:42:09Z,,0,0,090000648544d7ce
FDA-2011-N-0655-0032,FDA,FDA-2011-N-0655,Animal Generic Drug User Fee Act; Public Meeting; Request for Comments; Extension of Comment Period,Notice,Request for Comments,2022-10-20T04:00:00Z,2022,10,2022-10-20T04:00:00Z,2022-11-15T04:59:59Z,2022-11-15T02:01:26Z,2022-22744,0,0,090000648543b167
FDA-2011-N-0655-0031,FDA,FDA-2011-N-0655,Animal Generic Drug User Fee Act; Public Meeting; Request for Comments,Notice,Request for Comments,2022-09-30T04:00:00Z,2022,9,2022-09-30T04:00:00Z,2022-11-10T04:59:59Z,2022-09-30T14:55:22Z,2022-21304,0,0,0900006485389d63